MoneyWorks4Me

Cipla dissolves step down wholly owned subsidiary

29 Aug 2022 Evaluate

Cipla Med pro Holdings (Pty), wholly owned subsidiary of Cipla Med pro South Africa (Pty) and a wholly owned step-down subsidiary of the Cipla, has been dissolved with effect from August 25, 2022. Cipla Med pro Holdings (Pty) was a dormant entity and this dissolution will not affect performance or revenue of the company.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1437.65 21.65 (1.53%)
20-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1901.00
Dr. Reddys Labs. 1181.35
Cipla 1437.65
Lupin 2203.10
Zydus Lifesciences 1108.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: